Key Points
13 SLNO insiders filed coordinated Form 4 dispositions on May 18, 2026.
CEO Anish Bhatnagar led with 583,656 common shares sold.
Officers Manning and Fulk exercised options worth $6.9 million combined.
D-Return transactions likely represent routine vesting and tax withholding events.
Insider trading signals are like reading tea leaves at a board meeting. When executives suddenly sell shares in coordinated waves, it tells a story. On May 18, 2026, Soleno Therapeutics, Inc. (SLNO) experienced a major insider selling event. Thirteen company insiders filed Form 4 disclosures reporting dispositions of common stock and employee stock options. This coordinated insider selling activity involved directors, officers, and the CEO, totaling over 900,000 shares and options. The scale and timing of these insider transactions warrant close attention from investors tracking SLNO.
Massive Insider Selling Wave Hits SLNO on May 18
All 13 insider transactions occurred on the same date, May 18, 2026. CEO Anish Bhatnagar led the charge, disposing of 583,656 common shares in a single transaction. This represents the largest individual insider sale in the group. The coordinated timing suggests a planned, company-sanctioned event rather than random individual decisions.
Other major sellers included Chief Commercial Officer Meredith Manning (91,000 employee stock options at $46.31 per share, valued at $4.2 million) and Chief Financial Officer Jennifer Fulk (67,660 employee stock options at $39.06 per share, valued at $2.6 million). These high-value option exercises signal significant executive confidence in the company’s valuation at those strike prices.
Directors and Officers Participate in Coordinated Dispositions
Directors including Sinclair Andrew, Bir Dawn Carter, Pauls Matthew, Volck Birgitte, and Mark W. Hahn all filed Form 4 filings reporting share dispositions. Bir Dawn Carter disposed of the most shares among directors at 16,991 common shares. Volck Birgitte exercised 2,666 stock options at $5.03 per share, generating $13,410 in value.
Officers beyond the C-suite also participated. Chief Development Officer Manher Joshi sold 20,171 common shares. Chief Business Officer Kevin Norrett disposed of 17,786 common shares. Officers Hirano Patricia C and Yen Kristen each sold approximately 22,000 to 37,600 common shares respectively. The breadth of participation across leadership levels indicates this was a structured, company-wide event.
Understanding D-Return Transactions and Form 4 Filings
All 13 transactions are classified as D-Return dispositions on Form 4 filings. D-Return transactions typically represent returns of shares or options to the company, often related to tax withholding obligations during equity vesting or option exercise events. This is standard practice when employees exercise stock options or when restricted stock units vest.
The SEC filing data shows transaction dates matching filing dates on May 18, 2026. Most transactions involved common stock dispositions without disclosed prices, except for option exercises where strike prices were clearly stated. The absence of price data for common stock sales suggests these may be return-to-company transactions rather than open-market sales. Meyka AI rates SLNO a B+ grade, reflecting solid fundamentals despite this insider activity.
What This Insider Selling Pattern Means for SLNO Investors
Coordinated insider selling on a single date typically reflects planned equity events rather than loss of confidence. Companies often schedule option exercises and vesting events strategically. The total volume of 900,000+ shares and options disposed represents a significant capital event for the company and its leadership.
Investor interpretation depends on context. If these are routine vesting and option exercise events with tax withholding, they carry minimal bearish signal. However, the scale and simultaneity warrant monitoring. The company’s market cap of $2.76 billion provides substantial liquidity to absorb these dispositions. Tracking future insider buying activity will be key to assessing management confidence in SLNO’s direction.
Final Thoughts
On May 18, 2026, thirteen Soleno Therapeutics insiders filed coordinated Form 4 dispositions totaling over 900,000 shares and options. CEO Anish Bhatnagar led the selling with 583,656 common shares, while executives like Meredith Manning and Jennifer Fulk exercised high-value options. These D-Return transactions likely represent planned vesting and option exercise events with tax withholding rather than panic selling. The coordinated timing and breadth across leadership suggest a structured company event. Investors should monitor whether follow-up insider buying emerges to confirm management confidence in SLNO’s fundamentals.
FAQs
D-Return represents a disposition of securities, typically when employees exercise stock options or restricted stock vests with shares returned to cover tax withholding. It’s a routine transaction.
Coordinated selling typically indicates a planned company event like a scheduled vesting date or option exercise window. This is normal and doesn’t signal loss of confidence.
Over 900,000 shares and options were disposed. Priced transactions totaled approximately $6.9 million. Most common stock sales lacked disclosed prices.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)